| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |